Skip to content

Efficacy of Application of Myriad Matrix to Split Thickness Skin Graft Sites

Efficacy of Application of Myriad Matrix to Split Thickness Skin Graft Sites

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06647394
Enrollment
0
Registered
2024-10-17
Start date
2025-03-31
Completion date
2028-02-29
Last updated
2025-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Grafts

Brief summary

To determine if application of Myriad Matrix to split thickness skin graft donor sites improves post-operative pain and appearance of the wound.

Detailed description

In the head and neck practice at UAB, split thickness skin grafts are a commonly used procedure for simple reconstruction. The standard dressing for donor sites is a strip of vaseline gauze which remains on the site the wound dries, and the gauze eventually falls off. Post operative pain and poor wound healing is a well established complication of the donor site, and various methods have been studied in an attempt to reduce these complications for patients in the post operative period. (1, 2, 3) Myriad matrix is an engineered extracellular matrix (Ovine Forestomach Matrix) used for soft issue repair in complex wounds. This has been sporadically used by some of the faculty members at UAB for split thickness skin graft donor site dressings with anectodal improvement in pain and healing, though this has not yet been studied to our knowledge.

Interventions

PROCEDUREMatrix Dressing

extracellular matrix dressing soaked in 4% topical lidocaine to the skin graft donor site

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients 18 and over who are undergoing a split thickness skin graft at UAB.

Exclusion criteria

* Patients who are not planned to undergo a split thickness skin graft or who are unable or do not plan to attend follow up appointments will not be included.

Design outcomes

Primary

MeasureTime frameDescription
Pain Improvement48 hours, 2 weeks, 4-6 weeks post operative visitpatients will rate pain level at donor site
Wound Healing2 weeks and 4-6 weeks post operative visitPatients will rate appearance of would using the scar-Q questionnaire

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026